▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2867 by analyst upside · 2026-09-27
ACHC
Acadia Healthcare Company, Inc.
Healthcare · Market Cap $3B · P/E 0x
ANALYST PRICE TARGET
+20.3%
implied upside to consensus target
Current Price $28.09
Consensus Target $33.79
Bull Target $41.0
Bear Target $17.0
Analysts Covering 14
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
7
Hold
5
Sell
1
52-Week Low $11.43
52-Week High $35.83
YTD Return +96.6%
FUNDAMENTALS
Market Cap $3B
P/E Ratio (TTM) N/A
Forward P/E 15.2x
EPS (TTM) $-12.42
PEG Ratio 1.37
Dividend Yield N/A
Revenue (TTM) $3.4B
Profit Margin -33.4%
52-WEEK RANGE
52-Week Low $11.43
52-Week High $35.83
Current Price $28.09
Bear Target $17.0
Bull Target $41.0
● Now $28.09 ● Target $33.79
TRADING DATA
Avg Volume 2.2M
YTD Return +96.6%
Analyst Count 14
Consensus Buy
Upside to Target +20.3%
Last Updated 2026-09-27

ANALYST SUMMARY

Acadia Healthcare Company, Inc. (ACHC) is currently trading at $28.09 with a Wall Street consensus price target of $33.79, implying potential upside of 20.3% over the next 12 months. 14 analysts currently cover ACHC, with a consensus rating of Buy - 57% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $41.0, while the most cautious has a target of $17.0.

ACHC operates in the Healthcare sector with a market capitalisation of $3B. The stock is up 96.6% year-to-date and is currently trading near the upper end of its 52-week range of $11.43 – $35.83.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for ACHC, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Leerink Partners - Reiterated
Market Perform → Market Perform 2026-09-23 29% win rate (7 calls)
Guggenheim - Reiterated
Buy → Buy 2026-07-30 62% win rate (8 calls)
Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-07-30 Building track record
Guggenheim - Reiterated
Buy → Buy 2026-07-20 62% win rate (8 calls)
TD Cowen - Reiterated
Buy → Buy 2026-07-14 Building track record
Keybanc - Reiterated
Overweight → Overweight 2026-07-14 Building track record
UBS - Reiterated
Buy → Buy 2026-07-09 33% win rate (6 calls)
Jefferies ↑ Upgrade
Hold → Buy 2026-06-03 50% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
41
out of 100
Coverage depth
21/30
Consensus clarity
13/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →